These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 20069580)

  • 1. PEGylation of therapeutic proteins.
    Jevsevar S; Kunstelj M; Porekar VG
    Biotechnol J; 2010 Jan; 5(1):113-28. PubMed ID: 20069580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstacles and pitfalls in the PEGylation of therapeutic proteins.
    Gaberc-Porekar V; Zore I; Podobnik B; Menart V
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):242-50. PubMed ID: 18283612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size comparison between proteins PEGylated with branched and linear poly(ethylene glycol) molecules.
    Fee CJ
    Biotechnol Bioeng; 2007 Nov; 98(4):725-31. PubMed ID: 17461424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylation, successful approach to drug delivery.
    Veronese FM; Pasut G
    Drug Discov Today; 2005 Nov; 10(21):1451-8. PubMed ID: 16243265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cancer PEG-enzymes: 30 years old, but still a current approach.
    Pasut G; Sergi M; Veronese FM
    Adv Drug Deliv Rev; 2008 Jan; 60(1):69-78. PubMed ID: 17869378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEG conjugates in clinical development or use as anticancer agents: an overview.
    Pasut G; Veronese FM
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1177-88. PubMed ID: 19671438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein carboxyl amidation increases the potential extent of protein polyethylene glycol conjugation.
    Li S; Yang Z; Sun X; Tan Y; Yagi S; Hoffman RM
    Anal Biochem; 2004 Jul; 330(2):264-71. PubMed ID: 15203332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging PEGylated drugs.
    Kang JS; Deluca PP; Lee KC
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):363-80. PubMed ID: 19453284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugates of peptides and proteins to polyethylene glycols.
    Morpurgo M; Veronese FM
    Methods Mol Biol; 2004; 283():45-70. PubMed ID: 15197302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyethylene-glycol conjugated recombinant human acetylcholinesterase serves as an efficacious bioscavenger against soman intoxication.
    Kronman C; Cohen O; Raveh L; Mazor O; Ordentlich A; Shafferman A
    Toxicology; 2007 Apr; 233(1-3):40-6. PubMed ID: 17045722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of extension arm in PEG-Hb conjugates on the stability of the tetramer: non-conservative EAF maleimide thio-PEG mediated PEGylation.
    Ananda K; Acharya SA
    Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(6):499-512. PubMed ID: 19085194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Product development issues for PEGylated proteins.
    Payne RW; Murphy BM; Manning MC
    Pharm Dev Technol; 2011 Oct; 16(5):423-40. PubMed ID: 20858059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linear and branched bicin linkers for releasable PEGylation of macromolecules: controlled release in vivo and in vitro from mono- and multi-PEGylated proteins.
    Zhao H; Yang K; Martinez A; Basu A; Chintala R; Liu HC; Janjua A; Wang M; Filpula D
    Bioconjug Chem; 2006; 17(2):341-51. PubMed ID: 16536464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Native PAGE eliminates the problem of PEG-SDS interaction in SDS-PAGE and provides an alternative to HPLC in characterization of protein PEGylation.
    Zheng C; Ma G; Su Z
    Electrophoresis; 2007 Aug; 28(16):2801-7. PubMed ID: 17702059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylation and its impact on the design of new protein-based medicines.
    Ginn C; Khalili H; Lever R; Brocchini S
    Future Med Chem; 2014; 6(16):1829-46. PubMed ID: 25407370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of strong anion-exchangers for the purification of a PEGylated protein.
    Pabst TM; Buckley JJ; Ramasubramanyan N; Hunter AK
    J Chromatogr A; 2007 Apr; 1147(2):172-82. PubMed ID: 17346720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG - a versatile conjugating ligand for drugs and drug delivery systems.
    Kolate A; Baradia D; Patil S; Vhora I; Kore G; Misra A
    J Control Release; 2014 Oct; 192():67-81. PubMed ID: 24997275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
    Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S
    Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of PEGylation on biological therapies.
    Veronese FM; Mero A
    BioDrugs; 2008; 22(5):315-29. PubMed ID: 18778113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.